Cosmo Bio Company,Limited (3386.T)
JPY 1154.0
(0.17%)
JPY 1154.0
(0.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 736 Million | 284 Million | 648 Million | 803 Million | 569 Million |
| Net Income | 653 Million | 790 Million | 1.09 Billion | 1 Billion | 238 Million |
| Depreciation & Amortization | 148 Million | 141 Million | 166 Million | 175 Million | 207 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 154 Million | -361 Million | -96 Million | -54 Million | 2 Million |
| Other non-cash items | -75 Million | -52 Million | -178 Million | -35 Million | 549 Million |
| Investing Cash Flow | -758 Million | -291 Million | -145 Million | 42 Million | -135 Million |
| Investments in PPE | -100 Million | -104 Million | -141 Million | -65 Million | -182 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -700 Million | -502 Million | -100 Million | -200 Million | -150 Million |
| Sales/Maturities of investments | 52 Million | 306 Million | 100 Million | 309 Million | 200 Million |
| Other Investing Activities | -18 Million | -13 Million | -4 Million | -2 Million | -2 Million |
| Financing Cash Flow | -201 Million | -236 Million | -420 Million | -97 Million | -85 Million |
| Debt repayment | - | - | - | - | - |
| Dividends payments | -197 Million | -232 Million | -223 Million | -94 Million | -82 Million |
| Common Stock Repurchased | - | - | -194 Million | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -2 Million | -2 Million | -1 Million | -1 Million | -2 Million |
| Accounts receivables | -40 Million | -73 Million | 75 Million | -338 Million | -173 Million |
| Accounts payables | 21 Million | - | 75 Million | -78 Million | 16 Million |
| Inventory | 97 Million | -267 Million | -245 Million | 245 Million | 144 Million |
| Other working capital | 14 Million | -5 Million | -51 Million | -4 Million | 15 Million |
| Cash at beginning of period | 3.03 Billion | 3.25 Billion | 3.15 Billion | 2.41 Billion | 2.06 Billion |
| Cash at end of period | 2.82 Billion | 3.03 Billion | 3.25 Billion | 3.15 Billion | 2.41 Billion |
| Capital Expenditure | -100 Million | -104 Million | -141 Million | -65 Million | -182 Million |
| Effect of forex changes on cash | 13 Million | 24 Million | 12 Million | -5 Million | -1 Million |
| Net cash flow / Change in cash | -210 Million | -219 Million | 96 Million | 743 Million | 348 Million |
| Free Cash Flow | 636 Million | 180 Million | 507 Million | 738 Million | 387 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 28 Million | 230 Million | 76 Million | 653 Million | 5 Million | 97 Million |
| Depreciation & Amortization | - | - | - | 148 Million | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | 154 Million | - | - |
| Other non-cash items | -28 Million | -230 Million | -76 Million | -75 Million | -5 Million | -97 Million |
| Investing Cash Flow | - | - | - | -758 Million | - | - |
| Investments in PPE | - | - | - | -100 Million | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -700 Million | - | - |
| Sales/Maturities of investments | - | - | - | 52 Million | - | - |
| Other Investing Activities | - | - | - | -18 Million | - | - |
| Financing Cash Flow | - | - | - | -201 Million | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | -197 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | -2 Million | - | - |
| Accounts receivables | - | - | - | -40 Million | - | - |
| Accounts payables | - | - | - | 21 Million | - | - |
| Inventory | - | - | - | 97 Million | - | - |
| Other working capital | - | - | - | 14 Million | - | - |
| Cash at beginning of period | - | - | - | 3.03 Billion | - | - |
| Cash at end of period | - | - | - | 2.82 Billion | - | - |
| Capital Expenditure | - | - | - | -100 Million | - | - |
| Effect of forex changes on cash | - | - | - | 13 Million | - | - |
| Net cash flow / Change in cash | - | - | - | -210 Million | - | - |
| Free Cash Flow | - | - | - | 636 Million | - | - |
CULT
002641
BK
RAC
VICO
MND